Prázdny
0,00 €
 
-2 %
Bad Blood : Secrets and Lies in a Silicon Valley Startup

Bad Blood : Secrets and Lies in a Silicon Valley Startup

Dátum vydania: 21.03.2019
The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female ...
Bežná cena knihy: 16,44 €
Naša cena knihy: 16,11 €
Ušetríte: 2 %
Zasielame: Vypredané
Detaily o knihe
Počet strán: 320
Rozmer: 130x198x22 mm
Hmotnosť: 252 g
Jazyk: Anglicky
EAN: 9781509868087
Rok vydania: 2019
Žáner: Angličtina - beletrie
Typ: Paperback
Zákazníci, ktorí si kúpili túto knihu, si kúpili aj...
Kritická onemocnění průdušnice
Miloš Hájek
0,00 €
OLIVER ONIONS  FUTURE MEMORABILIA (LIMITED EDITION)
Bertelsmann Music Gr
22,79 €
Český rok od jara do zimy
Motlová Milada
38,44 €
Nebojuj s větrem, naslouchej srdcem
Brož Jaroslav
10,94 €
Český Krakov, české Malopolsko
Leszek Mazan; Agnieszka Buchtová; Renata Putzlacher
0,00 €
O knihe
The full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup -unicorn- promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. In Bad Blood, John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley. Now to be adapted into a film, with Jennifer Lawrence to star.